EP2825558

F. HOFFMANN-LA ROCHE AG
Application Number
EP13708435A
Filing Date
Mar 11, 2013
Status
Granted And Under Opposition
Apr 12, 2019
Grant Date
May 15, 2019
External Links
Slate, Register

Biblio Summary

The patent EP2825558B1 was granted on May 15, 2019 by F. Hoffmann-La Roche Ag The patent is currently Granted And Under Opposition.

The table below shows 10 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ZENTIVA PHARMA GMBHAug 28, 2024INTERVENTION ADMISSIBLE
AMGENFeb 17, 2020WITHDRAWN
CELLTRION INC.Feb 17, 2020WITHDRAWN
DR. REDDY'S LABORATORIES LIMITEDFeb 17, 2020WITHDRAWN
GRUNECKER PATENT- UND RECHTSANWALTE PARTG MBBFeb 17, 2020WITHDRAWN
DEHMEL & BETTENHAUSEN PATENTANWALTE PARTMBBFeb 14, 2020ADMISSIBLE
MABXIENCE RESEARCH, S.L.Feb 14, 2020ADMISSIBLE
STADAFeb 14, 2020ADMISSIBLE
HOFFMANN EITLE PATENT- UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBFeb 14, 2020WITHDRAWN
POHLMAN, SANDRA M.Feb 14, 2020WITHDRAWN

The table below shows the patents of F. Hoffmann-La Roche Ag that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3257564Overload And Elute ChromatographyMay 29, 20241
EP3294770Therapeutic And Diagnostic Methods For CancerMar 20, 20242
EP3998095Device For Sustained Delivery Of A Therapeutic FluidJan 31, 20241